New trends in the treatment of osteogenesis imperfecta type III – own experience

Journal Title: Ortopedia Traumatologia Rehabilitacja - Year 2008, Vol 10, Issue 6

Abstract

Introduction: Osteogenesis imperfecta (OI) is a genetic disorder caused by a mutation in the genes that encode the chains of type I collagen. Clinical manifestations include increased bone fragility and blue sclerae. OI type III is the most severe form with fractures occurring already in utero. Fracture immobilisation and orthopaedic surgery are the mainstay of treatment for patients with OI, and are combined with rehabilitation and bisphosphonate therapy.Patients and methods: The study involved 8 children with osteogenesis imperfecta type III, aged 1 month to 6 years. All of them were treated with cyclic intravenous infusions of pamidronate. Laboratory studies conducted before and after each 3-day cycle of pamidronate therapy included complete blood count, serum calcium, phosphorus, magnesium, osteocalcin, and calcium/creatinine index in morning urine and collagen type I cross-linked N-telopeptide (NTx). Infant total body densitometric scans were obtained in 5/8 patients.Results: Patients were treated for periods of 3-58 months. Fracture rates decreased with treatment in all patients compared to the prenatal period. Pamidronate also slowed down bone turnover, and particularly the resorption rate. The most common side effects during treatment included hypocalcaemia (7/8 patients) and fever (up to 39°C) after the first cycle of treatment.Conclusion: Symptomatic bisphosphonate therapy in children with osteogenesis imperfecta ameliorated the clinical course (decreased bone pain and reduced incidence of fractures). Pamidronate therapy had a positive impact on functional parameters such as independence in everyday activities and better mobility. The treatment was safe.

Authors and Affiliations

Elżbieta Jakubowska-Pietkiewicz , Danuta Chlebna-Sokół

Keywords

Related Articles

Fixation of patellar tendon bone graft in reconstruction of patellar ligaments. Comparison of bioabsorbable and metal interference screws - results of treatment.

Abstract Background. The central third of the patella tendon is probably the most common ACL graft material because the bone tendon bone (BTB) construct provides robust graft incorporation and a mechanically sufficient s...

Quality of life of physicians and their patients

Background. The aim of this study was to assess the quality of life (QOL) of healthy physicians and their patients in the context of an orthopedic department.Material and methods. Two groups of men participated in anonym...

Evaluation of the survivability of femoral shaft reconstructions after resection of tumor and tumor-like lesions

Background. The reconstruction of femoral shaft defects after tumor resection involves joining healthy bone fragments with plates or intramedullary rods, using methyl metacrylate cement or bone grafts.Material and method...

Treatment of femoral shaft union disturbances with intramedullary nailing. Treatment failure

Introduction: The paper contains an analysis of the treatment outcomes of intramedullary nailing for femoral shaft non-union. Materials: Twenty-two patients were treated between 1999 and 2005 with locked intramedullary...

Subacute Acetabular Osteomyelitis Caused by Proteus Mirabilis. A Case Study

Subacute acetabular osteomyelitis is a rare disease of bone. Deep location of the infection site sometimes may delay diagnosis. The most common cause is Staphylococcus aureus, whereas Proteus organisms are very rare etio...

Download PDF file
  • EP ID EP56861
  • DOI -
  • Views 106
  • Downloads 0

How To Cite

Elżbieta Jakubowska-Pietkiewicz, Danuta Chlebna-Sokół (2008). New trends in the treatment of osteogenesis imperfecta type III – own experience. Ortopedia Traumatologia Rehabilitacja, 10(6), 593-601. https://europub.co.uk/articles/-A-56861